CIK 0001555279
- Non-accelerated filer
- Smaller reporting company
908 Devices Inc.
Sign in to watch- Ticker
- MASS
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454524096
- Phone
- +1 978-729-4478
- Business address
- 44 THIRD AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,405,653
- in 9 filings, $1.5M under 10b5-1 plans
Net −$2,405,653. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-17 | Brown Christopher D. Director | Exercise or conversion | +54,318 | $1.75 | $95K | 829,877 |
| 2026-11-17 | Brown Christopher D. Director | Exercise or conversion · Stock Option (option to buy) | −54,318 | 0 | ||
| 2026-11-04 | Brown Christopher D. Director | Sale 10b5-1 | −30,000 | $10.95 | $329K | 775,559 |
| 2026-10-07 | Brown Christopher D. Director | Sale 10b5-1 | −30,000 | $11.89 | $357K | 745,559 |
| 2026-10-07 | Brown Christopher D. Director | Exercise or conversion 10b5-1 | +60,000 | $1.75 | $105K | 805,559 |
| 2026-10-07 | Brown Christopher D. Director | Exercise or conversion · Stock Option (option to buy) 10b5-1 | −60,000 | 54,318 | ||
| 2026-10-06 | Griffith Joseph H. IV Chief Financial Officer | Sale 10b5-1 | −5,000 | $13.03 | $65K | 116,497 |
| 2026-09-29 | AWM Investment Company, Inc. 10% owner | Sale | −18,000 | $11.52 | $207K | 4,736,773 |
| 2026-09-24 | AWM Investment Company, Inc. 10% owner | Sale | −24,000 | $11.36 | $273K | 4,754,773 |
| 2026-09-23 | AWM Investment Company, Inc. 10% owner | Sale | −1,000 | $11.25 | $11K | 4,755,773 |
| 2026-09-17 | Kenneweg John SVP, Sales & Product Marketing | Exercise or conversion 10b5-1 | +5,257 | $0.96 | $5K | 63,041 |
| 2026-09-17 | Kenneweg John SVP, Sales & Product Marketing | Sale 10b5-1 | −5,257 | $10.22 | $54K | 57,784 |
| 2026-09-17 | Kenneweg John SVP, Sales & Product Marketing | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −5,257 | 0 | ||
| 2026-09-16 | Kenneweg John SVP, Sales & Product Marketing | Exercise or conversion 10b5-1 | +21,399 | $0.96 | $21K | 79,183 |
| 2026-09-16 | Kenneweg John SVP, Sales & Product Marketing | Sale 10b5-1 | −21,399 | $10.11 | $216K | 57,784 |
| 2026-09-16 | Kenneweg John SVP, Sales & Product Marketing | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −21,399 | 5,257 | ||
| 2026-09-15 | Kenneweg John SVP, Sales & Product Marketing | Exercise or conversion 10b5-1 | +1,000 | $0.96 | $960 | 58,784 |
| 2026-09-15 | Kenneweg John SVP, Sales & Product Marketing | Sale 10b5-1 | −1,000 | $10.00 | $10K | 57,784 |
| 2026-09-15 | Kenneweg John SVP, Sales & Product Marketing | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −1,000 | 26,656 | ||
| 2026-09-02 | Brown Christopher D. Director | Sale 10b5-1 | −30,000 | $10.58 | $317K | 775,559 |
Page 1 of 39 · 769 trades